نهج Mayo Clinic

Mayo Clinic doctors have extensive experience with PSMA PET scans. The expert radiologists at Mayo Clinic have used this and other innovative tests to detect prostate cancer for many years.

Your Mayo Clinic care team

For those living with advanced prostate cancer, Mayo Clinic Comprehensive Cancer Center offers compassionate and personalized care. Cancer specialists work in teams with doctors from other specialties to provide you with exactly the care you need.

If you're considering a PSMA PET scan, your care team might include:

Experience that helps you get the right diagnosis

Mayo Clinic radiologists are experienced in using PSMA PET scans and other imaging tests to accurately detect and monitor prostate cancer.

  • Expertise in nuclear imaging. Mayo Clinic campuses in Arizona, Florida and Minnesota have cyclotrons, PET radiochemistry laboratories and nuclear radiopharmacies, all of which are needed to properly handle and produce the tracers for PET imaging and other nuclear imaging tests. Each campus also has state-of-the-art scanners, including PET-CT, PET-MRI and SPECT-CT.
  • Experience interpreting PET scans. Mayo Clinic radiologists read and interpret thousands of PET scans each year. The radiologists who read PSMA PET scans use their experience with this imaging test to help them distinguish cancer from something that isn't cancer. Having an experienced radiologist on your team helps give you the most accurate diagnosis.
  • A history of innovation in prostate cancer imaging. Mayo Clinic in Rochester, Minnesota, was the first medical center in the United States to receive approval by the U.S. Food and Drug Administration to prepare and administer the imaging agent used in a choline C-11 PET scan. This PET scan tracer was the first one developed specifically for imaging prostate cancer.

Access to the latest prostate cancer treatments

If a PSMA PET scan detects metastatic prostate cancer, there are many treatment options. A caring team of experts at Mayo Clinic can explain your options and help you pick the treatment that's best for you.

  • Radiopharmaceuticals and other advanced treatments. Mayo Clinic doctors offer the latest prostate cancer treatments, such as targeted therapy and immunotherapy. They also offer radiopharmaceuticals and nuclear medicine therapy, including lutetium Lu-177 vipivotide tetraxetan, which is known by the brand name Pluvicto.
  • Clinical trials studying the latest treatments. Mayo Clinic offers many clinical trials that give you a chance to try new treatments or new ways of using existing treatments.

الخبرة و مراتب التصنيف

Mayo Clinic doctors are widely respected for their expertise in using advanced imaging tests, such as the PSMA PET scan for prostate cancer. When you seek care at Mayo Clinic, you can expect:

  • Personalized care. At Mayo Clinic, an expert team of radiologists, urologists, medical oncologists, radiation oncologists and other specialists, if needed, work together to give you exactly the care you need. Mayo Clinic specialists have extensive experience caring for people with prostate cancer.
  • Experience you can trust. Mayo Clinic doctors are respected for their experience in caring for people with prostate cancer and for using PET scans to diagnose cancer and other conditions. Each year, more than 23,000 people with prostate cancer receive care at Mayo Clinic. Thousands of PET scans are done at Mayo Clinic facilities every year.
  • A full range of treatment options. If you're found to have metastatic prostate cancer, you have many treatment options. Mayo Clinic offers all prostate cancer treatments, including the latest treatments. Options may include hormone therapy, radiopharmaceutical treatments, targeted therapy, immunotherapy, surgery, cryotherapy and chemotherapy.
  • Center of excellence for radiopharmaceutical treatments. The Society of Nuclear Medicine and Molecular Imaging has designated Mayo Clinic as a Radiopharmaceutical Therapy Center of Excellence. This honor extends to the Mayo Clinic campuses in Arizona, Florida and Minnesota.
  • Nationally recognized expertise. Mayo Clinic Comprehensive Cancer Center meets the strict standards for a National Cancer Institute-designated comprehensive cancer center. These standards recognize scientific excellence and a multispecialty approach focused on cancer prevention, diagnosis and treatment.

صنَّفت شبكة U.S. News & World Report مايو كلينك في مدينة روتشستر بولاية مينيسوتا ومايو كلينك في مدينة جاكسونفيل بولاية فلوريدا ومايو كلينك في فينيكس/سكوتسديل بولاية أريزونا، ضمن أفضل المستشفيات لعلاج السرطان. صنَّفت شبكة U.S. News & World Report مايو كلينك في مدينة روتشستر بولاية مينيسوتا كأفضل مستشفى في ولاية مينيسوتا، ومايو كلينك في مدينة فينيكس/سكوتسديل بولاية أريزونا كأفضل مستشفى في ولاية أريزونا، وصُنفت مايو كلينك في جاكسونفيل بولاية فلوريدا كأفضل مستشفى في فلوريدا.

المواقع والسفر والسكن

لدى Mayo Clinic مجمعات رئيسية في فينيكس وسكوتسديل في أريزونا؛ وجاكسونفيل في فلوريدا؛ وروتشستر في مينيسوتا. يضم نظام Mayo Clinic الصحي عشرات المواقع في عدة ولايات.

لمزيد من المعلومات حول زيارة Mayo Clinic، اختر أحد المواقع أدناه:

التكاليف والتأمين

تعمل مايو كلينك بالتعاون مع المئات من شركات التأمين، وهي ضمن شبكة التغطية التأمينية للملايين من الناس.

وفي معظم الحالات، لا تشترط مايو كلينك وجود إحالة من طبيب. بينما تشترط بعض الجهات المؤمِّنة وجود إحالة أو قد تفرض شروطًا إضافية للحصول على رعاية طبية محددة. تتحدد أولوية كل المواعيد بناءً على الحاجة الطبية.

تعرَّف على المزيد عن المواعيد الطبية في مايو كلينك.

الرجاء الاتصال بشركة التأمين للتحقق من تغطيتك الطبية، وأيضًا للحصول على أي موافقات ضرورية منها قبل زيارة الطبيب. في كثير من الأحيان، يكون رقم خدمة عملاء الجهة المؤمِّنة مطبوعًا على ظهر بطاقة التأمين.

02/05/2025
  1. Prostate cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459. Accessed March 18, 2025.
  2. Fact sheet: Molecular imaging and prostate cancer. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Patients/Fact-Sheets/Molecular-Imaging-and-Prostate-Cancer.aspx. Accessed March 31, 2025.
  3. PET/CT. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/pet. Accessed March 24, 2025.
  4. Partin AW, et al., eds. Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed March 24, 2025.
  5. Fendler WP, et al. PSMA PET/CT: Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. European Journal of Nuclear Medicine and Molecular Imaging. 2023; doi:10.1007/s00259-022-06089-w.
  6. Illuccix (prescribing information). Telix Pharmaceuticals; 2023. https://www.illuccix.com. Accessed March 31, 2025.
  7. Gozellix (prescribing information). Telix Pharmaceuticals; 2025. https://www.gozellix.com. Accessed March 31, 2025.
  8. Locametz (prescribing information). Novartis; 2023. https://www.locametz-hcp.com. Accessed March 31, 2025.
  9. Posluma (prescribing information). Blue Earth Diagnostics; 2024. https://www.posluma.com. Accessed March 31, 2025.
  10. Pylarify (prescribing information). Progenics Pharmaceuticals; 2023. https://www.pylarify.com. Accessed March 31, 2025.
  11. Taplin ME, et al. Initial staging and evaluation of males with newly diagnosed prostate cancer. https://www.uptodate.com/contents/search. Accessed March 31, 2025.
  12. Westphalen AC, et al. Rising serum PSA following local therapy for prostate cancer: Diagnostic evaluation. https://www.uptodate.com/contents/search. Accessed March 31, 2025.
  13. 177-Lu PSMA-617 therapy, (Pluvicto). Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx. Accessed April 4, 2025.
  14. Radiation dose. Radiologyinfo.org. https://www.radiologyinfo.org/en/info/safety-xray. Accessed March 31, 2025.
  15. Voter AF, et al. A practical guide to the pearls and pitfalls of PSMA PET imaging. Seminars in Nuclear Medicine. 2023; doi:10.1053/j.semnuclmed.2023.11.001.
  16. Health Education & Content Services. About your PET/CT scan. Mayo Clinic; 2018.
  17. Health Education & Content Services. PET/MRI scan. Mayo Clinic; 2021.
  18. Nuclear medicine and radiation safety. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Fact-Sheet--Nuclear-Medicine-and-Radiation-Safety.aspx. Accessed March 31, 2025.
  19. Choline C 11 Injection (approval letter). New Drug Application 203155. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155. Accessed April 4, 2025.
  20. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024.
  21. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024.
  22. Radiopharmaceutical therapy centers of excellence. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Web/Clinical-Practice/Radiopharmaceutical-Therapy-Centers-of-Excellence. Accessed March 31, 2025.

ذات صلة

أخبار من مايو كلينك